Sandra Milligan
President chez ASPIRA WOMEN'S HEALTH INC.
Fortune : 575 421 $ au 31/03/2024
Profil
Mme Sandra Milligan est un administrateur indépendant de Gossamer Bio, Inc. et un responsable de la recherche et du développement chez Organon & Co. Elle est membre du conseil d'administration de Gossamer Bio, Inc. Mme Milligan était auparavant employée par Genentech, Inc. en tant que vice-présidente des affaires réglementaires. Elle a obtenu son diplôme de premier cycle à l'Université de Californie, Irvine, un diplôme d'études supérieures au Georgetown University Law Center et un doctorat à la George Washington University School of Medicine & Health.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ORGANON & CO.
0,01% | 04/05/2023 | 28 599 ( 0,01% ) | 537 661 $ | 31/03/2024 |
GOSSAMER BIO, INC.
0,01% | 15/11/2023 | 32 000 ( 0,01% ) | 37 760 $ | 31/03/2024 |
Postes actifs de Sandra Milligan
| Sociétés | Poste | Début |
|---|---|---|
| GOSSAMER BIO, INC. | Director/Board Member | 10/06/2021 |
| ASPIRA WOMEN'S HEALTH INC. | President | 01/04/2024 |
Anciens postes connus de Sandra Milligan
| Sociétés | Poste | Fin |
|---|---|---|
| ORGANON & CO. | Chief Tech/Sci/R&D Officer | 01/01/2024 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 01/04/2020 |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Director/Board Member | 01/01/2017 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2015 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2012 |
Formation de Sandra Milligan
| University of California, Irvine | Undergraduate Degree |
| Georgetown University Law Center | Graduate Degree |
| George Washington University School of Medicine & Health | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| ASPIRA WOMEN'S HEALTH INC. | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| ORGANON & CO. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Commercial Services |
| The United States Army Medical Service Corps |
